Biophysical Gatekeeping: A Critical Quality Attribute (CQA) Framework for Liposomal Delivery Systems

Liposomal encapsulation has redefined the delivery of drugs and nutrients by mimicking natural biological membranes. Despite their potential, transitioning these microscopic vesicles from the laboratory to large-scale industrial production is often hindered by physical inconsistency. This review from West Bengal Chemical Industries Limited (WBCIL) introduces “Biophysical Gatekeeping,” a structured protocol that replaces traditional trial-and-error formulation methods with precise, measurable formulation engineering. At its core is WBCIL’s proprietary LipoEdge™ technology, an advanced manufacturing platform that designs Critical Quality Attributes (CQAs) directly into the liposomal architecture.

The framework organises quality control into four sequential gates. Gate I, Vesicle architecture, confirms that particles have the correct size, shape, and low polydispersity index (PDI) for predictable biodistribution and colloidal stability. Gate II, Surface Chemistry, validates the electrical charge and protective coatings, including PEGylation, chitosan, and pectin, that prevent vesicle clumping and premature clearance in the bloodstream. Gate III, Compositional Efficiency, ensures that at least 80% of the active ingredient is successfully encapsulated, with loading capacities reaching up to 71% in advanced formulations. Gate IV, Biological Validation, tests the formulation’s ability to survive gastric acid, cross the intestinal epithelial barrier via Caco-2 permeation assays, and enter systemic circulation through the lymphatic pathway.